United Kingdom, United Kingdom

Paul Barnett

This inventor holds 2 USPTO granted patents. Top assignee: Societe D'exploitation De Produits Pour Les Industries Chimiques Seppic. Active years: 2003-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paul Barnett. Retrieved from https://idiyas.com/inventor/paul-barnett

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Pirbright, GB (2003)
  • Grande-Bretagne, GB (2010)

Company Filing History:


Years Active: 2003-2010

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Paul Barnett: Innovator in Vaccine Technology

Introduction

Paul Barnett is a notable inventor based in the United Kingdom, recognized for his contributions to vaccine technology. With a total of 2 patents, he has made significant strides in the field of immunology.

Latest Patents

Barnett's latest patents focus on stratified and cryogenically stored vaccines. The first patent describes a composition that includes at least one antigenic medium and at least one adjuvant. In this composition, both the antigenic medium and the adjuvant consist of distinct phases when in a solid state. The composition transitions to a liquid state when its temperature reaches or exceeds 4°C. This innovative approach aims to enhance the efficacy and stability of vaccines.

Career Highlights

Paul Barnett is currently employed at Société d'Exploitation de Produits pour les Industries Chimiques Seppic. His work at this company has allowed him to explore advanced methodologies in vaccine preparation and storage.

Collaborations

Barnett has collaborated with notable colleagues, including Vincent Ganne and Jérome Aucouturier. These partnerships have contributed to the development of his innovative vaccine technologies.

Conclusion

Paul Barnett's work in vaccine technology exemplifies the importance of innovation in the medical field. His patents reflect a commitment to improving vaccine stability and efficacy, which is crucial for public health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…